Back to Search
Start Over
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
- Source :
- Blood; September 2023, Vol. 142 Issue: 13 p1131-1142, 12p
- Publication Year :
- 2023
-
Abstract
- •Geriatric assessments can aid in identifying patients with less physical resilience who are at increased risk of grade ≥3 adverse events.•Fixed-duration Ven-O improves HRQoL in patients with CLL with and without geriatric impairments.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 13
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs63418620
- Full Text :
- https://doi.org/10.1182/blood.2023020195